Search companies

Live

MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED (ASX: MVP)

Health care · News and insights

Price unavailable

Latest MVP announcements

MVP Reports FY26 Growth, Sets Out Penthrox Expansion Priorities

2026-11-12 · Health care

MVP: $0.440 +0.00% · MC: $50M

Medical Developments International reported FY26 revenue growth of 9% to $43 million, a small EBIT profit and free cash flow that improved by $6 million, while Penthrox volumes rose across regions. At its AGM, the company said it expects continued progress in the year ahead through efforts to deepen Penthrox use and expand into new geographies and segments; shareholders approved its new rights plan.

Updated 2026-11-12 17:23
Share
Sources2026 Annual General Meeting Chair and CEO Address2026 Annual General Meeting PresentationResults of 2026 Annual General Meeting2026 Annual General Meeting Recording
Comments